Gerald B. Appel spends much of his time researching Kidney disease, Internal medicine, Glomerulonephritis, Pathology and Lupus nephritis. His biological study spans a wide range of topics, including Glomerulosclerosis, Nephrotic syndrome, Surgery and Urology. As part of his studies on Internal medicine, Gerald B. Appel often connects relevant subjects like Gastroenterology.
His Glomerulonephritis research is multidisciplinary, relying on both Monoclonal Immunoglobulin Deposition Disease and Monoclonal. Gerald B. Appel interconnects Membranoproliferative glomerulonephritis, Proteinuria, Renal pathology, Eculizumab and Creatinine in the investigation of issues within Pathology. The concepts of his Lupus nephritis study are interwoven with issues in Cyclophosphamide, Maintenance therapy, Immunology, Lupus erythematosus and Connective tissue disease.
Gerald B. Appel mainly focuses on Internal medicine, Immunology, Glomerulonephritis, Gastroenterology and Pathology. His work in Internal medicine addresses subjects such as Nephropathy, which are connected to disciplines such as Immunoglobulin A. His Immunology research integrates issues from Lupus nephritis and Disease.
His Glomerulonephritis research is multidisciplinary, relying on both Eculizumab, Immunopathology and Renal pathology. The concepts of his Gastroenterology study are interwoven with issues in Surgery, Retrospective cohort study and Mycophenolate. He interconnects Glomerulosclerosis, Kidney and Glomerulopathy in the investigation of issues within Pathology.
Gerald B. Appel mainly investigates Internal medicine, Gastroenterology, Nephropathy, Kidney disease and Focal segmental glomerulosclerosis. In general Internal medicine study, his work on Membranous nephropathy, Glomerulonephritis, Renal function and Proteinuria often relates to the realm of In patient, thereby connecting several areas of interest. He has included themes like Autoantibody, Rituximab, Immunology and Renal pathology in his Glomerulonephritis study.
His research in Nephropathy tackles topics such as Randomized controlled trial which are related to areas like Surrogate endpoint. His Kidney disease research includes elements of Exome sequencing, Exome, Emergency medicine and Intensive care medicine. His studies deal with areas such as Nephrotic syndrome, Disease and Allele as well as Focal segmental glomerulosclerosis.
His primary scientific interests are in Internal medicine, Kidney disease, Focal segmental glomerulosclerosis, Nephropathy and Membranous nephropathy. His research links Gastroenterology with Internal medicine. His study in Kidney disease is interdisciplinary in nature, drawing from both Exome sequencing, Exome, Gene expression, Disease and Genotype.
His studies in Nephropathy integrate themes in fields like Randomized controlled trial and Renal function. His Nephrotic syndrome course of study focuses on Urology and Pathology. His Proteinuria research includes themes of Creatinine and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Jan J. Weening;Vivette D. D'Agati;Melvin M. Schwartz;Surya V. Seshan.
Journal of The American Society of Nephrology (2004)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
Ellen M. Ginzler;Mary Anne Dooley;Cynthia Aranow;Mimi Y. Kim.
The New England Journal of Medicine (2005)
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†
Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney.
Arthritis & Rheumatism (2012)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)
Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis
Mary Anne Dooley;David Jayne;Ellen M. Ginzler;David Isenberg.
The New England Journal of Medicine (2011)
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler.
American Journal of Nephrology (2004)
C3 glomerulopathy: consensus report
Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith.
Kidney International (2013)
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
Glen S. Markowitz;Gerald B. Appel;Paul L. Fine;Andrew Z. Fenves.
Journal of The American Society of Nephrology (2001)
Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.
Vivette D'Agati;Jung-Il Suh;Laura Carbone;Jen-Tse Cheng.
Kidney International (1989)
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update
Gerald B. Appel;H. Terence Cook;Gregory Hageman;J. Charles Jennette.
Journal of The American Society of Nephrology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Columbia University
Columbia University
Mayo Clinic
Columbia University
University Health Network
University of Pennsylvania
University of North Carolina at Chapel Hill
Mayo Clinic
University of Alabama at Birmingham
University of Alabama at Birmingham
The University of Texas at Dallas
University of Pennsylvania
National Research Council (CNR)
University of Waikato
Boston University
University of Gothenburg
Aix-Marseille University
Aston University
Osnabrück University
National Institutes of Health
Vrije Universiteit Amsterdam
Nanjing University
Baylor University
St. Jude Children's Research Hospital
Rowan University
Heidelberg University